04/15/2026 15:29
Chaired by HRH Crown Prince, PIF Board of Directors Approves PIF 2026-2030 Strategy

The Board of Directors of PIF, chaired by His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince, Prime Minister and Chairman of the Board of Directors of PIF, has approved PIF’s 2026-2030 strategy, which is a continuation of PIF’s long-term strategy. The strategy will focus on delivering competitive domestic ecosystems to connect sectors, unlock the full potential of strategic assets, maximize long-term returns, and continue to drive the economic transformation of Sa...

04/15/2026 19:07
South African Agency Boundless Delivers Mazda’s First AI-produced Commercial Using Luma Agents

Luma AI today announced that Boundless, an independent creative agency based in Johannesburg, South Africa, has produced Mazda’s first AI-produced commercial using Luma Agents, Luma’s AI-powered creative workflow system. Delivered in less than two weeks from initial brief to final approval, the project marks a significant step in the use of AI-native workflows for commercial production. As part of the collaboration, Boundless has also signed an agreement with Luma to integrate the company’s AI ...

04/15/2026 21:32
Skild AI Acquires Zebra Technologies' Robotics Automation Business

Skild AI today announced the acquisition of Zebra Technologies' Robotics Automation business, including its Symmetry Fulfillment orchestration platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415518240/en/ The Skild Brain — the industry's first omnibodied AI software designed to operate without prior knowledge of a robot's exact body form — can control any robot, across any task, in any warehouse environment. With Zebra's...

04/16/2026 02:00
Toshiba Starts Sample Shipments of New “SmartMCD™” Series Product Integrating Microcontroller and Motor Driver

Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has started to ship engineering samples of “TB9M030FG,” the latest addition to its “SmartMCD™”[1] series of motor control devices. The new device integrates a microcontroller (MCU) and a motor driver, and incorporates sensorless control technology for low‑speed operation of three‑phase brushless DC motors. TB9M030FG is suitable for sensorless control of the three‑phase brushless DC motors used in automotive applications, such as e...

04/16/2026 05:01
Ferring Pharmaceuticals and Gallup Announce Landmark Global Public Attitudes Study on Fertility and Family-Building

Ferring Pharmaceuticals and Gallup today announced the Ferring Global Fertility Monitor, a global study on the factors influencing people’s fertility choices, at the 2026 Annual Convening of Semafor World Economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415305082/en/ The Ferring Global Fertility Monitor is grounded in the recognition that declining global fertility rates are an increasingly significant public policy topic,...

04/16/2026 05:00
Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of Regenerating Skin Nectar with TriHex+™, the newest innovation from Alastin, a leader in peptide-based regenerative skincare. As a pioneer in peri‑procedural skincare, Alastin helped establish the category with the original Regenerating Skin Nectar — one of the first products specifically developed to prepare the skin before cosmetic procedures, complement procedural outcomes, and visibly support a s...

04/16/2026 06:00
Juvisé Pharmaceuticals Formally Approved the Appointments of Frédéric Mascha as Executive Chairman and Chairman of the Supervisory Committee and the Nomination of Renaud Sermondade as the Group’s New CEO

At the Board of Directors meeting held on April 15, 2026, Juvisé Pharmaceuticals officially acknowledged the resignation of Frédéric Mascha from his role as CEO of the pharmaceutical group and his appointment as Executive Chairman and Chairman of the Supervisory Committee. The Board of Directors appointed Renaud Sermondade as the Group’s new CEO, effective July 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415884303/en/...